TrialLeukemia research2011

High dose cytarabine plus gemtuzumab ozogamicin for patients with relapsed or refractory acute myeloid leukemia: Cancer and Leukemia Group B study 19902.

Richard M Stone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.